Silo Pharma, Inc. (NASDAQ:SILO) Sees Significant Increase in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 115,000 shares, a growth of 87.3% from the March 31st total of 61,400 shares. Currently, 4.5% of the shares of the company are short sold. Based on an average daily volume of 216,600 shares, the days-to-cover ratio is currently 0.5 days.

Silo Pharma Trading Down 1.6 %

SILO stock traded down $0.03 on Friday, hitting $1.85. The company had a trading volume of 55,867 shares, compared to its average volume of 440,773. Silo Pharma has a 12-month low of $1.22 and a 12-month high of $3.05. The stock’s 50-day simple moving average is $1.80 and its 200 day simple moving average is $1.60.

About Silo Pharma

Silo Pharma. Inc, a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. The company's developing solutions to address various underserved conditions. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders.